May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC
Apr 22, 2025, 10:51

Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospital, shared a post on LinkedIn:

“Today is day of press release.

Sacituzumab govitecan plus pembrolizumab shows PFS benefit over chemo plus Pembrolizumab in metastatic TNBC with CPS > 10.

Ascent 04 trial.

Looking forward to Magnitude of benifit.”

Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC